IHH Healthcare - RHB Invest 2024-03-01: Ending The Year With Record High Revenue; Keep BUY

• IHH Healthcare (SGX:Q0F)'s 4Q23 core profit came off by 28% q-o-q to MYR266m (below expectations) amid a seasonally weaker quarter due to the holiday and festive seasons.
• We continue to like IHH Healthcare given its reputable regional footprint across key regions, its organic expansion target (+33% bed capacity by 2028), and resilient demand for healthcare services.
• - Read this at SGinvestors.io -

Results overview.

• IHH Healthcare's FY23 full-year core earnings came in at 91% and 79% of our and Street’s estimates, which we deem as below expectations, no thanks to increases in staff and utilities costs, and a weakening TRY.
• - Read this at SGinvestors.io -
• In 2023, IHH Healthcare’s operational beds grew to 12,307 (2022: 11,881 beds). Group bed occupancy rate (BOR) contracted slightly (69% vs 2022’s 70%).

Segmental breakdown.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2025-11-27 IHH Healthcare - Post-PBT Items Drag Earnings; Still BUY.

Previous report by RHB:
2025-11-10 IHH Healthcare - On Track For Recovery; Maintain BUY.

Price targets by other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News